| Reference : Successful treatment of equine sarcoids with cisplatin electrochemotherapy: a retrospect... |
| Scientific journals : Article | |||
| Life sciences : Veterinary medicine & animal health | |||
| http://hdl.handle.net/2268/124927 | |||
| Successful treatment of equine sarcoids with cisplatin electrochemotherapy: a retrospective study of 48 cases. | |
| English | |
| Tamzali, Y [Université de Toulouse, INP, ENVT, Toulouse, France > > > >] | |
Borde, Laura [Université de Liège - ULg > Département clinique des animaux de compagnie et des équidés > Médecine interne des équidés >] | |
| Rols, MP [IPBS, UMR 5089, CNRS and University of Toulouse, Toulouse, France. > > > >] | |
| Golzio, M [IPBS, UMR 5089, CNRS and University of Toulouse, Toulouse, France. > > > >] | |
| Lyazrhi, F [Université de Toulouse, INP, ENVT, Toulouse, France > > > >] | |
| Teissie, J [IPBS, UMR 5089, CNRS and University of Toulouse, Toulouse, France. > > > >] | |
| Mar-2012 | |
| Equine Veterinary Journal | |
| Equine Veterinary Journal Ltd | |
| 44 | |
| 2 | |
| 214-220 | |
| International | |
| 0425-1644 | |
| Newmarket Suffolk | |
| United Kingdom | |
| [en] REASONS FOR PERFORMING STUDY: Sarcoids are the commonest form of equine skin tumour. Several therapeutic measures have been described but none is considered to be universally effective. Electrochemotherapy (ECT) is a new anticancer therapy that utilises electrical field pulses to induce increased cell membrane permeability to antitumour hydrophilic drugs, such as cisplatin. The increased intracellular concentration of the drugs has a significant therapeutic benefit. The procedure has not been previously reported in a large number of horses.
OBJECTIVE: To validate ECT as a novel alternative treatment for equine sarcoids. METHODS: A retrospective study evaluating the efficacy of cisplatin ECT in the treatment of equine sarcoids was performed. Electrochemotherapy treatments were applied under general anaesthesia at 2 week intervals with or without prior excision or debulking. Electric pulses were directly applied to the lesions following intra-tumoural injections of an aqueous solution of cisplatin. RESULTS: One-hundred-and-ninety-four sarcoids on 34 horses, 2 ponies, 11 donkeys and one mule were treated with ECT. The 4 year nonrecurrence rate was 97.9% for animals (47/48) and 99.5% (193/194) for tumours. When ECT was used as a single treatment, a significant influence of tumour size (ρ= 0.55) on the number of treatments required for cure was shown. When prior surgery was performed, there was a significant influence (P<0.001) of the excision quality (complete or incomplete) and the healing mode (closed or open wound) on the number of treatments. The most common adverse effect was a slight oedematous reaction for lesions located on thin skin regions. CONCLUSION AND CLINICAL RELEVANCE: Results demonstrate that ECT, with or without concurrent tumour debulking, is an effective alternative for treatment of equine sarcoids | |
| http://hdl.handle.net/2268/124927 |
| File(s) associated to this reference | ||||||||||||||
|
Fulltext file(s):
| ||||||||||||||
All documents in ORBi are protected by a user license.